New research reveals key driver of drug resistance in certain lung cancers
Researchers with the Lockwood Lab at BC Cancer examined why certain lung tumours manage to resist treatment over time, and what can be done to reduce resistance.
News
Dr. Pamela Hoodless receives NSERC Discovery Grant
Congratulations to Dr. Pamela Hoodless for receiving a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).
Dr. Hoodless, a distinguished researcher and Interim Head, Basic and Translational Research at BC Cancer, will use the grant to support her work in defining cell lineages and plasticity in the developing liver.
Natural Language Processing can reduce workload, increase timeliness and improve quality of breast cancer care
A new BC Cancer project has been shown to expedite the triaging of breast cancers and accelerate the initiation of treatment.
The CAN-TRI-NLP, or a “CANcer TRIage system to expedite care with Natural Language Processing” project, was funded through the Ministry of Health's Innovation Pathway Program to explore a new expedited breast cancer triage system for faster initiation of appropriate treatment, chemotherapy or surgery.
Exercise improves survival for colon cancer patients
In a world-first clinical trial, a team of international researchers working with the Canadian Cancer Trials Group (CCTG) have demonstrated that a structured exercise program significantly improves survival for colon cancer patients by reducing the risk of disease recurrence and new primary cancers.
The groundbreaking seventeen-year study involved researchers from UBC’s Faculty of Medicine as well as researchers at 55 sites across Canada, Australia and the United Kingdom.
New Inpatient Clinical Trials Unit Launches in Vancouver to Advance Blood Cancer Treatment Across BC
British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers has been launched by Vancouver Coastal Health in collaboration with BC Cancer physicians and scientists. Located at Vancouver General Hospital (VGH), the new Hematology Research Unit will deliver revolutionary therapies — including first-in-human treatments such as advanced immunotherapies like CAR T-cell therapy — to patients with relapsed or treatment-resistant hematological diseases.
Canada joins Federated EGA, establishing a significant global repository for secure sharing of human genomic and health data
Canada’s Michael Smith Genome Sciences Centre at BC Cancer hosts the Canadian Node of the Federated EGA
In a major milestone for international biomedical research and the future of personalized medicine, the Canadian Genome-Phenome Archive (CGA), part of the Pan-Canadian Genome Library (PCGL) has joined the Federated European Genome-Phenome Archive (Federated EGA), marking the federation’s first significant expansion outside of Europe.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.